EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity

Chethan M Puttarajappa, Kenneth J Smith, Bestoun H Ahmed, Karla Bernardi, Linda-Marie Lavenburg, William Hoffman, Michele Molinari

American Journal of Transplantation · 2024

DOI: 10.1016/j.ajt.2024.07.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Transplantation, 2024. Verfasst von Chethan M Puttarajappa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Surgery, Thomas E. Starzl …. Hauptthemen laut MEDLINE: Kidney Transplantation, Weight Loss, Obesity, Cost-Benefit Analysis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Allergy and Infectious Diseases, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel antiobesity medications, particularly glucagon-like peptide-1 receptor agonists (GLP-1RAs), have expanded weight loss (WL) options for kidney transplantation (KT) candidates with obesity beyond lifestyle modifications and bariatric surgery. However, varying effectiveness, risk profiles, and costs make strategy choices challenging. To aid decision-making, we used a Markov model to examine the cost-effectiveness of different WL strategies over a 10-year horizon. A target WL of 15% of total body weight was used for the base case scenario, and we compared these strategies to a "liberal" KT strategy of transplanting candidates with obesity. Outcomes included costs (2023 US dollars), quality-adjusted life years, and incremental cost-effectiveness ratios. In analysis, a liberal KT strategy was favored over lifestyle modifications and GLP-1RAs. Among WL strategies, bariatric surgery was the most effective and cost the least, whereas lifestyle modification had the highest cumulative costs and was the least effective. Compared to liberal KT, bariatric surgery costs $45 859 per quality-adjusted life year gained. GLP-1RAs were favored over bariatric surgery only when drug costs were below $5000 per year (base cost $12 077). In conclusion, for KT candidates with obesity, a liberal KT strategy and bariatric surgery are preferred over lifestyle modifications alone and GLP-1RAs based on outcomes and cost-effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationWeight LossObesityCost-Benefit AnalysisBariatric SurgeryHumansMaleQuality-Adjusted Life YearsFemaleMarkov ChainsMiddle AgedKidney Failure, ChronicPrognosisFollow-Up StudiesAdult

Stichwörter der Autor:innen

bariatric surgerydecision analysisglucagon-like peptide-1 receptor agonistkidney transplantationobesity

Autor:innen und Institutionen

  • Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Penns…
  • Section of Decision Sciences, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Surgery, Bariatric and Minimally Invasive and Bariatric Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Transplant Nephrology, University of Pittsburgh Medical Center Harrisburg, Harrisburg, Pennsylvania, USA.
  • Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Surgery, Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Förderung

  • NIDDK NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIDDK
  • Sanofi Pasteur
  • Istituto di Neuroscienze della Fondazione Cavalieri Ottolenghi
  • National Institutes of Health

Zitieren

APA

Puttarajappa, C. M., Smith, K. J., Ahmed, B. H., Bernardi, K., Lavenburg, L. M., Hoffman, W., & Molinari, M. (2024). Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2024.07.024

Vancouver

Puttarajappa CM, Smith KJ, Ahmed BH, Bernardi K, Lavenburg LM, Hoffman W, et al. Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity. American Journal of Transplantation. 2024. doi:10.1016/j.ajt.2024.07.024

BibTeX
@article{Puttarajappa2024,
  author = {Puttarajappa, Chethan M and Smith, Kenneth J and Ahmed, Bestoun H and Bernardi, Karla and Lavenburg, Linda-Marie and Hoffman, William and Molinari, Michele},
  title = {Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity},
  journal = {American Journal of Transplantation},
  year = {2024},
  doi = {10.1016/j.ajt.2024.07.024}
}
Kostenlos starten →